Astellas Pharma, Inc./ US04623U1025 /
7/5/2024 9:59:30 PM | Chg. +0.2150 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
10.0200USD | +2.19% | 117,047 Turnover: 1.11 mill. |
-Bid Size: - | -Ask Size: - | 21.22 bill.USD | - | - |
GlobeNewswire
4/16
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Dir...
GlobeNewswire
3/19
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degene...
GlobeNewswire
2/26
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire
2/7
LAPIX Therapeutics Strengthens Board of Directors with Appointments of Pharmaceutical Industry Veter...
GlobeNewswire
12/11/2023
Basilea announces that FDA approves expanded use of antifungal Cresemba® (isavuconazole) in the Unit...
GlobeNewswire
10/19/2023
Basilea announces acquisition of novel clinical-stage antifungal for treatment of Aspergillus mold i...
GlobeNewswire
9/14/2023
Mineralys Therapeutics Expands its Board of Directors with Appointments of Glenn Sblendorio and Daph...
GlobeNewswire
9/11/2023
Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors
GlobeNewswire
3/11/2022
ENTA Conducting Clinical Trial of Investigational Regenerative Medication to Restore Hearing Functi...
GlobeNewswire
2/28/2022
Vallon Pharmaceuticals Announces Appointment of Meenu Karson to Board of Directors
GlobeNewswire
2/22/2022
Zenith Epigenetics Announces Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol...
GlobeNewswire
1/31/2022
Zenith Epigenetics Announces Appointment to Board of Directors and Provides Clinical Update